Active Ingredient(s):Monomethyl Fumarate FDA Approved: * April 28, 2020 Pharm Company: *BANNER LIFE SCIENCES Category:Multiple Sclerosis
Monomethyl fumarate, sold under the brand name Bafiertam is a medication for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is taken by mouth.
The most common adverse reactions are flushing, abdominal pain, diarrhea, and nausea.
It was approved for medical use in the United States in April 2020.[...
* May have multiple approval dates, manufacturers, or labelers.